Andy A. Liu, former President of IMS Health for Asia Pacific and China will be talking about opportunities in pharmaceuticals, biotech, medtech. The life sciences landscape is one of the most exciting places to be today. There are major changes with multi-national companies and even more changes across health tech startup companies. What are the key trends, what are the key opportunities, how will the landscape change and what impact will it have on Hong Kong and your business.
Andy A. Liu has over 20 years of experience in the life sciences industry. He is currently the Vice Chairman at HKBIO, responsible for International Affairs and driving commercialization. He was previously President for Asia Pacific and China at IMS Health where he was responsible for managing the business across 17 different countries in Asia.